Streptococcus salivarius subsp. thermophilus CCFM1312 enhanced mice resilience to activity-based anorexia.

Probiotic intervention, already showing promise in the treatment of various psychiatric disorders like depression, emerges as a potential therapy for anorexia nervosa (AN) with minimal side effects. In this study, we established an activity-based anorexia (ABA) model to probe the pathogenesis of AN and assess the impact of probiotics on ABA mice. ABA resulted in a compensatory increase in duodenal ghrelin levels, impairing the regulation of feeding and the brain reward system. Intervention with Streptococcus salivarius subsp. thermophilus CCFM1312 ameliorated these ABA-induced effects, and the activation of neurons in the nucleus tractus solitarius (NTS) was observed following probiotic administration, revealing the advantageous role of probiotics in AN through the vagus nerve. Furthermore, our metabolomics analysis of cecal contents unveiled that S. salivarius subsp. thermophilus CCFM1312 modulated gut microbiota metabolism and thereby regulated intestinal ghrelin levels.

Bifidobacterium breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial.

Psychobiotics, a newly identified category of probiotics primarily targeting the gut-brain axis, exhibit tremendous potential in improving sleep quality. In this study, the clinical trial was registered in advance (identifier: NO. ChiCTR2300067806). Forty participants who were diagnosed with stress-induced insomnia were chosen and randomly divided into two groups: one received CCFM1025 at a dose of 5 × 109 CFU (n = 20), while the other was administered a placebo (n = 20), over a period of four weeks. The results revealed that compared to the placebo group (pre: M = 10.10, SD = 2.292; post: M = 8.650, SD = 2.793; pre vs. post: F (1, 38) = 15.41, p = 0.4316), the CCFM1025-treated group exhibited a significant decrease in Pittsburgh Sleep Quality Index (PSQI) scores from baseline (pre: M = 11.60, SD = 3.169; post: M = 7.750, SD = 3.697, F (1, 38) = 15.41, p = 0.0007). Furthermore, the administration of CCFM1025 was associated with a more pronounced reduction in stress marker concentrations. This effect could potentially be linked to changes in serum metabolites induced by the probiotic treatment, notably daidzein. In conclusion, B. breve CCFM1025 demonstrates promise as a psychobiotic strain for enhancing sleep quality.

Soft Array Surface-Changing Compound Eye.

The field-of-view (FOV) of compound eyes is an important index for performance evaluation. Most artificial compound eyes are optical, fabricated by imitating insect compound eyes with a fixed FOV that is difficult to adjust over a wide range. The compound eye is of great significance in the field of tracking high-speed moving objects. However, the tracking ability of a compound eye is often limited by its own FOV size and the reaction speed of the rudder unit matched with the compound eye, so that the compound eye cannot better adapt to tracking high-speed moving objects. Inspired by the eyes of many organisms, we propose a soft-array, surface-changing compound eye (SASCE). Taking soft aerodynamic models (SAM) as the carrier and an infrared sensor as the load, the basic model of the variable structure infrared compound eye (VSICE) is established using an array of infrared sensors on the carrier. The VSICE model is driven by air pressure to change the array surface of the infrared sensor. Then, the spatial position of each sensor and its viewing area are changed and, finally, the FOV of the compound eye is changed. Simultaneously, to validate the theory, we measured the air pressure, spatial sensor position, and the FOV of the compound eye. When compared with the current compound eye, the proposed one has a wider adjustable FOV.